What if AI could decode government in real time? In this episode of Eye on AI, Craig Smith sits down with Pat Utz, CEO and Co-Founder of Abstract, the AI startup building "regulatory superintelligence" to track and analyze laws, bills, and regulations across 145,000+ government entities. Pat explains how Abstract evolved from university research into a venture-backed company helping law firms, enterprises, and policymakers cut through the noise of Congress, state legislatures, and regulatory agencies. From uncovering hidden amendments in massive bills to proactively identifying risks and opportunities for businesses, Abstract is transforming how we understand legislation. We cover: How AI is reshaping lobbying, law, and compliance Why Abstract is focused on proactive intelligence, not reactive compliance The role of AI agents, LLMs, and retrieval-augmented generation (RAG) in policy analysis Real examples of AI influencing funding and legislation The future of democracy when citizens and businesses have true transparency into government Whether you're in tech, law, government affairs, or just curious about how AI is changing democracy, this conversation reveals the future of policy intelligence. 🔗 Learn more about Abstract: https://www.abstract.us
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Before the Crisis: How You and Your Relatives Can Prepare for Financial Caregiving
06 Dec 2025
Motley Fool Money
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
Anthropic Finds AI Answers with Interviewer
05 Dec 2025
The Daily AI Show
#2423 - John Cena
05 Dec 2025
The Joe Rogan Experience
Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution
05 Dec 2025
McKinsey on Healthcare